missing translation for 'onlineSavingsMsg'
Learn More

Mouse Siglec-1/CD169 PE-conjugated Antibody, R&D Systems™

Rat Monoclonal Antibody has been used in 2 publications

Brand:  R&D Systems FAB5610P

Product Code. 18165491

  • € 438.00 / 100 tests

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Siglec-1/CD169 Monoclonal specifically detects Siglec-1/CD169 in Mouse samples. It is validated for Flow Cytometry.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Siglec-1/CD169
Monoclonal
R-PE
Supplied in a saline solution containing BSA and Sodium Azide. with Sodium Azide
CD169, FLJ00051, sialic acid binding Ig-like lectin 1, sialoadhesin, sialoadhesin, Siglec1
Rat
Protein A or G purified from hybridoma culture supernatant
RUO
6614
Mouse
Purified
Flow Cytometry
645608
Flow Cytometry 10 uL/10^6 cells
Q62230
SIGLEC1
Mouse myeloma cell line NS0-derived recombinant mouse Siglec-1/CD169 Thr20-Leu1639 (predicted) Accession # Q62230
100 Tests
Primary
Detects mouse Siglec-1/CD169 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human Siglec-1/CD169, -5, -6, -7, -8, -9, -10, -11, -14, recombinant mouse Siglec-2, -3, -E, -F, -G, or -H is observed.
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8 degreesC as supplied.
IgG2a
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.